Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Superoxide is a reactive oxygen species (ROS) formed by the one-electron reduction of molecular oxygen. It is a free radical that can cause oxidative damage to cells and tissues by inactivating iron-sulfur cluster-containing enzymes, releasing free iron, and initiating lipid peroxidation. Superoxide contributes significantly to oxidative stress and is implicated in various diseases. It is detoxified by superoxide dismutase (SOD), which converts it to hydrogen peroxide.
Superoxide itself is not directly targeted by drugs, but its effects are modulated. SOD mimetics catalyze the dismutation of superoxide to hydrogen peroxide and oxygen. Antioxidants scavenge free radicals, including those derived from superoxide.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superoxide (O₂⁻).